Ampio Pharmaceuticals Issues Letter to Stockholders

ENGLEWOOD, Colo., Aug. 3, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockhold...

Related Keywords

United States ,American ,Nic Johnson ,J Kevin Buchi ,Michaela Martino ,Mike Martino ,Kevin Buchi ,Exchange Commission ,Company Disclosure Committee ,Drug Administration ,Ampio Board Of Directors The Special Committee ,Ampio Pharmaceuticals Inc ,Ampio Pharmaceuticals ,Chief Executive Officer ,Fellow Stockholders ,Ampio Board ,Special Committee ,Disclosure Committee ,Executive Officer ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,